Cellular hypoxia reprograms drug response and reveals curcumin-driven cancer stem-cell-associated marker enrichment in oral squamous cell carcinoma

doi:10.4252/wjsc.121991

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 8

This Article

(1)

(0)

(5)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Stem Cells

ISSN

1948-0210

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Stem Cells. Aug 26, 2026; 18(8): 121991
Published online Aug 26, 2026. doi: 10.4252/wjsc.121991

Full Size Figure Download Figure

Figure 3 Total reactive oxygen species levels in live OECM-1 cells after treatment with carboplatin, curcumin, and curcumin combined with carboplatin under normoxic and hypoxic conditions. A: Normoxia; B: Hypoxia. Statistical analysis was performed using one-way ANOVA with Tukey’s multiple comparison test. ^aP < 0.0001, ^bP = 0.039, ^cP = 0.004, ^dP < 0.0001. ROS: Reactive oxygen species.

Citation: Alharbi HS, Rahman I, AlSheddi MA, Henidi H, Alkahtani MM, Al Makhlafi Z, ElRefai S, Altwaim SA, Alnofaie HS, Salem HM, Omar MG, Alturki A, Talic H, Aladhyani G, Alotaibi F, Basuhail H, Alotaibi R, Alturki N, Alharbi A, Alsultan R, Albassam SK. Cellular hypoxia reprograms drug response and reveals curcumin-driven cancer stem-cell-associated marker enrichment in oral squamous cell carcinoma. World J Stem Cells 2026; 18(8): 121991
URL: https://www.wjgnet.com/1948-0210/full/v18/i8/121991.htm
DOI: https://dx.doi.org/10.4252/wjsc.121991

Alharbi HS, Rahman I, AlSheddi MA, Henidi H, Alkahtani MM, Al Makhlafi Z, ElRefai S, Altwaim SA, Alnofaie HS, Salem HM, Omar MG, Alturki A, Talic H, Aladhyani G, Alotaibi F, Basuhail H, Alotaibi R, Alturki N, Alharbi A, Alsultan R, Albassam SK. Cellular hypoxia reprograms drug response and reveals curcumin-driven cancer stem-cell-associated marker enrichment in oral squamous cell carcinoma. World J Stem Cells 2026; 18(8): 121991 [DOI: 10.4252/wjsc.121991]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.